With the current recommendations for receptor screening, all tumors with one% or maybe more of beneficial cells for ER and/or PR should be regarded as hormone receptor good, and also the clients are for that reason candidates for endocrine therapy [95].Resulting from new success recently published from potential randomized clinical research on radi